[Antiplatelet drugs as a preventive measure of stroke--treatment strategies by subtypes of ischemic stroke].
作者信息
Yamaguchi T
出版信息
Rinsho Ketsueki. 1996 Sep;37(9):808-12.
PMID:8914467
Abstract
摘要
相似文献
1
[Antiplatelet drugs as a preventive measure of stroke--treatment strategies by subtypes of ischemic stroke].[抗血小板药物作为卒中预防措施——缺血性卒中亚型的治疗策略]
Rinsho Ketsueki. 1996 Sep;37(9):808-12.
2
Antiplatelet therapy in ischemic stroke: variability in clinical trials and its impact on choosing the appropriate therapy.缺血性卒中的抗血小板治疗：临床试验中的变异性及其对选择合适治疗方法的影响。
J Neurol Sci. 2009 Sep 15;284(1-2):1-9. doi: 10.1016/j.jns.2009.04.001. Epub 2009 Apr 19.
3
ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
Expert Rev Neurother. 2008 Nov;8(11):1661-5. doi: 10.1586/14737175.8.11.1661.
4
The role of antiplatelet therapy in stroke prevention.
Tenn Med. 1997 Nov;90(11):454-5.
5
Antiplatelet drugs in secondary prevention of stroke.
Int J Clin Pract. 1998 Mar;52(2):91-7.
6
Aspirin and dipyridamole for the secondary prevention of stroke.
J Fam Pract. 1999 Feb;48(2):92.
7
[Clopidogrel as basic therapy in high-risk stroke patients].
Praxis (Bern 1994). 2004 Aug 18;93(34):1364.
8
Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.稳定型心血管疾病患者服用低剂量阿司匹林的荟萃分析。
Am J Med. 2008 Jan;121(1):43-9. doi: 10.1016/j.amjmed.2007.10.002.
9
[Dipyridamole plus acetylsalicylic acid--who is to be trusted?].
Ugeskr Laeger. 1999 Aug 23;161(34):4771-2.
10
Anticoagulants and antiplatelet agents in acute ischemic stroke.
Va Med Q. 1998 Spring;125(2):125-7.
Zotero 插件